<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://newdrugapprovals.org/2026/05/17/engasertib/</loc><news:news><news:publication><news:name>New Drug Approvals</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-17T02:56:38+00:00</news:publication_date><news:title>Engasertib</news:title><news:keywords>Orphan Drug, serine/threonine kinase inhibitor, anax labs, engasertib, VAD-044</news:keywords></news:news></url><url><loc>https://newdrugapprovals.org/2026/05/16/encofosbuvir/</loc><news:news><news:publication><news:name>New Drug Approvals</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-16T02:31:45+00:00</news:publication_date><news:title>Encofosbuvir</news:title><news:keywords>antiviral, APPROVALS 2025, CHINA 2025, anax labs, encofosbuvir, HEC 110114; Yiqibuvir</news:keywords></news:news></url></urlset>
